Dr. Mead is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
1275 York Ave
New York, NY 10065Phone+1 212-639-6673Fax+1 718-920-2058- Is this information wrong?
Education & Training
- Montefiore Medical Center/Albert Einstein College of Medicine (Moses and Weiler Campuses)Fellowship, Pulmonary Disease and Critical Care Medicine, 2007 - 2010
- Montefiore Medical Center/Albert Einstein College of Medicine (Moses and Weiler Campuses)Residency, Internal Medicine, 2003 - 2006
- University of Massachusetts Medical SchoolClass of 2003
Certifications & Licensure
- NY State Medical License 2006 - 2026
- American Board of Internal Medicine Critical Care Medicine
- American Board of Internal Medicine Pulmonary Disease
Publications & Presentations
PubMed
- 82 citationsGPRC5D-Targeted CAR T Cells for Myeloma.Sham Mailankody, Sean M Devlin, Jonathan Landa, Karthik Nath, Claudia Diamonte, Elizabeth J Carstens, Douglas Russo, Romany Auclair, Lisa Fitzgerald, Briana Cadzin, Xi...> ;The New England Journal of Medicine. 2022 Sep 29
- 49 citationsModified EASIX predicts severe cytokine release syndrome and neurotoxicity after chimeric antigen receptor T cellsMartina Pennisi, Miriam Sanchez-Escamilla, Jessica Flynn, Roni Shouval, Ana Alarcon Tomas, Mari Lynne Silverberg, Connie Lee Batlevi, Renier J. Brentjens, Parstoo B Da...> ;Blood Advances. 2021 Sep 14
- 10 citationsCritically Ill Patients Treated for Chimeric Antigen Receptor-Related Toxicity: A Multicenter Study.Gutierrez, C., Cristina Gutierrez, Anne Rain T. Brown, Heather P. May, Amer Beitinjaneh, R. Scott Stephens, Prabalini Rajendram, Joseph L. Nates, Stephen M. Pastores, ...> ;Critical Care Medicine. 2021 Jul 2
- Join now to see all
Abstracts/Posters
- Easix and Modified-Easix Are Early Predictors of Severe Cytokine Release Syndrome and Neurotoxicity in Patients Treated with Chimeric Antigen Receptor T CellsElena Mead, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
- Impact and Safety of Chimeric Antigen Receptor T Cell Therapy in Vulnerable Older Patients with Relapsed/Refractory Diffuse Large B-Cell LymphomaElena Mead, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
- Comparing Gradings of Immune Effector Cells Toxicities: Application of Astct Consensus Grading System and Implications for Clinical ManagementElena Mead, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
- Join now to see all
Hospital Affiliations
- Memorial Sloan Kettering Cancer CenterNew York, New York
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: